Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress
GlobeNewswire
PDUFA target action date for tovorafenib NDA in relapsed or progressive pLGG remains set for April 30, 2024Phase 2 FIREFLY-1..
PDUFA target action date for tovorafenib NDA in relapsed or progressive pLGG remains set for April 30, 2024Phase 2 FIREFLY-1..
Results from FIREFLY-1 demonstrate overall response rate (ORR) of 67% and clinical benefit rate (CBR) of 93% in 69 heavily..
BRISBANE, Calif., April 12, 2023 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical..